PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsAcamprosate
Acamprosate
Acamprosate (acamprosate) is a small molecule pharmaceutical. Acamprosate was first approved as Campral on 2004-07-29. It is used to treat alcoholism in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
chemically-induced disordersD064419
mental disordersD001523
Trade Name
FDA
EMA
Acamprosate (discontinued: Acamprosate, Campral)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Acamprosate calcium
Tradename
Company
Number
Date
Products
CAMPRALForest LaboratoriesN-021431 DISCN2004-07-29
1 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
acamprosate calciumANDA2024-10-15
campralNew Drug Application2016-08-06
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
alcoholismEFO_0003829D000437F10.1
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
N: Nervous system drugs
N07: Other nervous system drugs in atc
N07B: Drugs used in addictive disorders
N07BB: Drugs used in alcohol dependence
N07BB03: Acamprosate
HCPCS
No data
Clinical
No data
Drug
General
Drug common nameAcamprosate
INNacamprosate
Description
Acamprosate calcium is an organic calcium salt. It contains an acamprosate(1-).
Classification
Small molecule
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CC(=O)NCCCS(=O)(=O)O
Identifiers
PDB
CAS-ID77337-76-9
RxCUI
ChEMBL IDCHEMBL1201293
ChEBI ID51041
PubChem CID155434
DrugBankDB00659
UNII IDN4K14YGM3J (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
£
No data
Estimated US medical usage
Acamprosate
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use